{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:08:36Z","timestamp":1789103316127,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04273-7","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:55:41Z","timestamp":1789102541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Conjunctival biopsy findings associated with fibrosis and sequelae in ocular Mucous membrane pemphigoid"],"prefix":"10.1007","volume":"46","author":[{"given":"Ariana","family":"Ringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Smichowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Nuncio","family":"Siegrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German Daniel","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro Adrian","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Oscar","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier Eduardo","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lorena","family":"Brance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rosa","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3540-6169","authenticated-orcid":false,"given":"Ignacio Javier","family":"Gandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"9","key":"4273_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/eye.2012.119","volume":"26","author":"CF Radford","year":"2012","unstructured":"Radford CF, Rauz S, Williams GP, Saw VPJ, Dart JKG (2012) Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom. Eye (Lond) 26(9):1199\u20131208. https:\/\/doi.org\/10.1038\/eye.2012.119","journal-title":"Eye (Lond)"},{"issue":"10","key":"4273_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41433-018-0155-7","volume":"32","author":"S Bobba","year":"2018","unstructured":"Bobba S, Devlin C, Di Girolamo N, Wakefield D, McCluskey P, Chan E et al (2018) Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand. Eye (Lond) 32(10):1636\u20131643. https:\/\/doi.org\/10.1038\/s41433-018-0155-7","journal-title":"Eye (Lond)"},{"issue":"9","key":"4273_CR3","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/jdv.17397","volume":"35","author":"H Rashid","year":"2021","unstructured":"Rashid H, Lamberts A, Borradori L, Alberti-Violetti S, Barry RJ, Caproni M et al (2021) European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology \u2013 part I. J Eur Acad Dermatol Venereol 35(9):1750\u20131764. https:\/\/doi.org\/10.1111\/jdv.17397","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"4273_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.preteyeres.2004.05.005","volume":"23","author":"M Ahmed","year":"2004","unstructured":"Ahmed M, Zein G, Khawaja F, Foster CS (2004) Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res 23(6):579\u2013592. https:\/\/doi.org\/10.1016\/j.preteyeres.2004.05.005","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"4273_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archderm.138.3.370","volume":"138","author":"LS Chan","year":"2002","unstructured":"Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ et al (2002) The first international consensus on mucous membrane pemphigoid. Arch Dermatol 138(3):370\u2013379. https:\/\/doi.org\/10.1001\/archderm.138.3.370","journal-title":"Arch Dermatol"},{"issue":"11","key":"4273_CR6","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1097\/ICO.0000000000002080","volume":"38","author":"F Fremont","year":"2019","unstructured":"Fremont F, Pelissier-suarez C, Fourni\u00e9 P, Porterie M, Thevenin A, Astudillo L et al (2019) Clinical characteristics and outcomes of ocular cicatricial pemphigoid: a cohort study and literature review. Cornea 38(11):1406\u20131411. https:\/\/doi.org\/10.1097\/ICO.0000000000002080","journal-title":"Cornea"},{"key":"4273_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2020.01.033","volume":"216","author":"G Coco","year":"2020","unstructured":"Coco G, Romano V, Menassa N, Borroni D, Iselin K, Finn D et al (2020) Conjunctival biopsy site in mucous membrane pemphigoid. Am J Ophthalmol 216:1\u20136. https:\/\/doi.org\/10.1016\/j.ajo.2020.01.033","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"4273_CR8","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1080\/09273948.2020.1716988","volume":"29","author":"SD Anesi","year":"2021","unstructured":"Anesi SD, Eggenschwiler L, Ferrara M, Artornsombudh P, Walsh M, Foster CS (2021) Reliability of conjunctival biopsy for diagnosis of ocular mucous membrane pemphigoid: redetermination of the standard for diagnosis and outcomes of previously biopsy-negative patients. Ocul Immunol Inflamm 29(6):1106\u20131113. https:\/\/doi.org\/10.1080\/09273948.2020.1716988","journal-title":"Ocul Immunol Inflamm"},{"key":"4273_CR9","doi-asserted-by":"publisher","first-page":"1257288","DOI":"10.3389\/fmed.2023.1257288","volume":"10","author":"B Jakubowska","year":"2023","unstructured":"Jakubowska B, Pietrzyk E, Maciejewicz P, Kowalewski C, Wozniak K (2023) Diagnostic and prognostic values of conjunctival and oral biopsies analyzed by direct immunofluorescence in patients with mucous membrane pemphigoid. Front Med (Lausanne). 10:1257288. https:\/\/doi.org\/10.3389\/fmed.2023.1257288","journal-title":"Front Med (Lausanne)."},{"issue":"4","key":"4273_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ophtha.2017.10.004","volume":"125","author":"HS Ong","year":"2018","unstructured":"Ong HS, Setterfield JF, Minassian DC, Dart JK, Booth D, Reid E et al (2018) Mucous membrane pemphigoid with ocular involvement: the clinical phenotype and Its relationship to direct immunofluorescence findings. Ophthalmology 125(4):496\u2013504. https:\/\/doi.org\/10.1016\/j.ophtha.2017.10.004","journal-title":"Ophthalmology"},{"issue":"10","key":"4273_CR11","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/jdv.17395","volume":"35","author":"E Schmidt","year":"2021","unstructured":"Schmidt E, Rashid H, Marzano AV, Lamberts A, Di ZG, Diercks GFH et al (2021) European guidelines ( S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology \u2013 Part II. J Eur Acad Dermatol Venereol 35(10):1926\u20131948. https:\/\/doi.org\/10.1111\/jdv.17395","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"4273_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/eye.2016.284","volume":"31","author":"JK Dart","year":"2017","unstructured":"Dart JK (2017) The 2016 Bowman lecture conjunctival curses: scarring conjunctivitis 30 years on. Eye (Lond) 31(2):301\u2013332. https:\/\/doi.org\/10.1038\/eye.2016.284","journal-title":"Eye (Lond)"},{"issue":"4","key":"4273_CR13","first-page":"179","volume":"45","author":"ML Racca","year":"2007","unstructured":"Racca ML, Lago N, Pelayes D, Berra A, Fari\u00f1a A, Monserrat A, Z\u00e1rate JO (2007) Penfigoide mucoso conjuntival, cicatricial o activo y su posible relaci\u00f3n patog\u00e9nica con alteraciones linfoproliferativas. Patolog\u00eda 45(4):179\u2013181","journal-title":"Patolog\u00eda"},{"issue":"2","key":"4273_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/ICO.0000000000003382","volume":"43","author":"N Jain","year":"2024","unstructured":"Jain N, Jakati S, Shanbhag SS, Basu S (2024) Direct immunofluorescence findings and factors affecting conjunctival biopsy positivity in ocular mucous membrane pemphigoid. Cornea 43(2):159\u2013165. https:\/\/doi.org\/10.1097\/ICO.0000000000003382","journal-title":"Cornea"},{"issue":"4-5","key":"4273_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/08820538.2011.588660","volume":"26","author":"M Kirzhner","year":"2011","unstructured":"Kirzhner M, Jakobiec FA (2011) Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current management. Semin Ophthalmol 26(4\u20135):270\u2013277. https:\/\/doi.org\/10.3109\/08820538.2011.588660","journal-title":"Semin Ophthalmol"},{"issue":"12","key":"4273_CR16","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1097\/ICO.0000000000003235","volume":"42","author":"AM Philip","year":"2023","unstructured":"Philip AM, Stephenson A, Al-Dabbagh A, Ramezani K, Fernandez-Santos CC, Foster CS (2023) Ocular cicatricial pemphigoid with IgM-positive biopsy. Cornea 42(12):1503\u20131505. https:\/\/doi.org\/10.1097\/ICO.0000000000003235","journal-title":"Cornea"},{"issue":"3","key":"4273_CR17","first-page":"134","volume":"91","author":"EH Chiganer","year":"2017","unstructured":"Chiganer EH, Albera P (2017) Penfigoide ocular cicatricial: hallazgos de biopsia conjuntival y su relaci\u00f3n con la inflamaci\u00f3n y cicatrizaci\u00f3n ocular. Rev Mex Oftalmol 91(3):134\u2013141","journal-title":"Rev Mex Oftalmol"},{"issue":"2","key":"4273_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1001\/jamadermatol.2022.5829","volume":"159","author":"K Kridin","year":"2023","unstructured":"Kridin K, Van Beek N, B\u00fchler E, Kochan AS, Ranjbar M, Beissert S et al (2023) Characteristics associated with refractory course, blindness, and treatment strategy-related outcomes in patients with mucous membrane pemphigoid. JAMA Dermatol 159(2):198\u2013203. https:\/\/doi.org\/10.1001\/jamadermatol.2022.5829","journal-title":"JAMA Dermatol"},{"issue":"10","key":"4273_CR19","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/jdv.17395","volume":"35","author":"E Schmidt","year":"2021","unstructured":"Schmidt E, Rashid H, Marzano AV, Lamberts A, Di Zenzo G, Diercks GFH et al (2021) European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II. J Eur Acad Dermatol Venereol 35(10):1926\u20131948. https:\/\/doi.org\/10.1111\/jdv.17395","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4273_CR20","first-page":"527","volume":"84","author":"CS Foster","year":"1986","unstructured":"Foster CS (1986) Cicatricial pemphigoid. Trans Am Ophthalmol Soc 84:527\u2013663","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"13","key":"4273_CR21","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2165\/00003495-200565130-00003","volume":"65","author":"C Laforest","year":"2005","unstructured":"Laforest C, Huilgol SC, Casson R, Selva D, Leibovitch I (2005) Autoimmune bullous diseases: ocular manifestations and management. Drugs 65(13):1767\u20131779. https:\/\/doi.org\/10.2165\/00003495-200565130-00003","journal-title":"Drugs"},{"issue":"2","key":"4273_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0161-6420(81)35069-6","volume":"88","author":"BJ Mondino","year":"1981","unstructured":"Mondino BJ, Brown SI (1981) Ocular cicatricial pemphigoid. Ophthalmology 88(2):95\u2013100. https:\/\/doi.org\/10.1016\/s0161-6420(81)35069-6","journal-title":"Ophthalmology"},{"issue":"4","key":"4273_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/s0002-9394(14)77908-5","volume":"96","author":"BJ Mondino","year":"1983","unstructured":"Mondino BJ, Brown SI (1983) Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol 96(4):453\u2013459. https:\/\/doi.org\/10.1016\/s0002-9394(14)77908-5","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4273_CR24","first-page":"33","volume":"25","author":"MC Castells","year":"2004","unstructured":"Castells MC (2004) Mastocytosis: classification, diagnosis, and clinical presentation. Allergy Asthma Proc 25(1):33\u201336","journal-title":"Allergy Asthma Proc"},{"key":"4273_CR25","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.1136\/ard.2009.10823319.https:\/\/cioms.ch\/wp-content\/uploads\/2017\/01\/WEB-CIOMS-EthicalGuidelines.pdf (last visit 26 May 2024)","DOI":"10.1136\/ard.2009.10823319"},{"key":"4273_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.rcreu.2020.12.006","volume":"29","author":"A Ringer","year":"2022","unstructured":"Ringer A, Grossi GD, Siegrist C, Cuadranti N, Ruffino JP, Argento MC et al (2022) Ocular cicatricial pemphigoid. From a rheumatology and ophthalmology point of view. Rev Colomb Reumatol 29:57\u201367. https:\/\/doi.org\/10.1016\/j.rcreu.2020.12.006","journal-title":"Rev Colomb Reumatol"},{"issue":"12","key":"4273_CR27","doi-asserted-by":"publisher","first-page":"1466491","DOI":"10.3389\/fcell.2024.1466491","volume":"17","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang P, Tang Y, Chen Y, Zhou E, Gao K (2024) Mast cells: a double-edged sword in inflammation and fibrosis. Front Cell Dev Biol 17(12):1466491. https:\/\/doi.org\/10.3389\/fcell.2024.1466491","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4273_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/imr.12623","volume":"282","author":"AM Piliponsky","year":"2018","unstructured":"Piliponsky AM, Romani L (2018) The contribution of mast cells to bacterial and fungal infection immunity. Immunol Rev 282(1):188\u2013197. https:\/\/doi.org\/10.1111\/imr.12623","journal-title":"Immunol Rev"},{"issue":"4","key":"4273_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/ICO.0000000000001477","volume":"37","author":"N Ebrahimiadib","year":"2018","unstructured":"Ebrahimiadib N, Hernandez M, Modjtahedi BS, Roohipoor CR, Foster CS (2018) Atopy in patients with ocular cicatricial pemphigoid. Cornea 37(4):436\u2013441. https:\/\/doi.org\/10.1097\/ICO.0000000000001477","journal-title":"Cornea"},{"issue":"4","key":"4273_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/imm.13556","volume":"167","author":"Y Luo","year":"2022","unstructured":"Luo Y, Zhang H, Yu J, Wei L, Li M, Xu W (2022) Stem cell factor\/mast cell\/CCL2\/monocyte\/macrophage axis promotes Coxsackievirus B3 myocarditis and cardiac fibrosis by increasing Ly6Chigh monocyte influx and fibrogenic mediators production. Immunology 167(4):590\u2013605. https:\/\/doi.org\/10.1111\/imm.13556","journal-title":"Immunology"},{"issue":"19","key":"4273_CR31","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.111.052399","volume":"124","author":"W Zhang","year":"2011","unstructured":"Zhang W, Chancey AL, Tzeng H-P, Zhou Z, Lavine K, Gao F et al (2011) The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions. Circulation 124(19):2106\u20132116. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.052399","journal-title":"Circulation"},{"issue":"1","key":"4273_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/wrr.12687","volume":"27","author":"BC Wulff","year":"2019","unstructured":"Wulff BC, Pappa NK, Wilgus TA (2019) Interleukin-33 encourages scar formation in murine fetal skin wounds. Wound Repair Regen 27(1):19\u201328. https:\/\/doi.org\/10.1111\/wrr.12687","journal-title":"Wound Repair Regen"},{"issue":"26","key":"4273_CR33","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1182\/blood.2022017326","volume":"140","author":"J Melo-Cardenas","year":"2022","unstructured":"Melo-Cardenas J, Bezavada L, Crawford JC, Gurbuxani S, Cotton A, Kang G et al (2022) IL-13\/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms. Blood 140(26):2805\u20132817. https:\/\/doi.org\/10.1182\/blood.2022017326","journal-title":"Blood"},{"key":"4273_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-immunol-071719-094903","volume":"38","author":"SJ Galli","year":"2020","unstructured":"Galli SJ, Gaudenzio N, Tsai M (2020) Mast cells in inflammation and disease: recent progress and ongoing concerns. Annu Rev Immunol 38:49\u201377. https:\/\/doi.org\/10.1146\/annurev-immunol-071719-094903","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"4273_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/s0002-9394(14)76821-7","volume":"86","author":"MR Allansmith","year":"1978","unstructured":"Allansmith MR, Greiner JV, Baird RS (1978) Number of inflammatory cells in the normal conjunctiva. Am J Ophthalmol 86(2):250\u2013259. https:\/\/doi.org\/10.1016\/s0002-9394(14)76821-7","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"4273_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fmed.2018.00201","volume":"10","author":"KT Amber","year":"2018","unstructured":"Amber KT, Valdebran M, Kridin K, Grando SA, Amber KT (2018) The role of eosinophils in bullous pemphigoid\u202f: a developing model of eosinophil pathogenicity in mucocutaneous disease. Front Med (Lausanne) 10(5):201. https:\/\/doi.org\/10.3389\/fmed.2018.00201","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"4273_CR37","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1167\/iovs.02-1084","volume":"44","author":"MS Razzaque","year":"2003","unstructured":"Razzaque MS, Ahmed BS, Foster CS, Ahmed AR (2003) Effects of IL-4 on conjunctival fibroblasts: possible role in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 44(8):3417\u20133423. https:\/\/doi.org\/10.1167\/iovs.02-1084","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"4273_CR38","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1111\/all.16318","volume":"79","author":"N Sun","year":"2024","unstructured":"Sun N, Ogulur I, Mitamura Y, Yazici D, Pat Y, Bu X et al (2024) The epithelial barrier theory and its associated diseases. Allergy 79(12):3192\u20133237. https:\/\/doi.org\/10.1111\/all.16318","journal-title":"Allergy"},{"issue":"2","key":"4273_CR39","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.ajpath.2011.04.015","volume":"179","author":"K Tsunoda","year":"2011","unstructured":"Tsunoda K, Ota T, Saito M, Hata T, Shimizu A, Ishiko A et al (2011) Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris. Am J Pathol 179(2):795\u2013806. https:\/\/doi.org\/10.1016\/j.ajpath.2011.04.015","journal-title":"Am J Pathol"},{"issue":"1","key":"4273_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/jalm\/jfab147","volume":"7","author":"KM Leiferman","year":"2022","unstructured":"Leiferman KM, Snook JP, Khalighi MA, Kuechle MK, Zone JJ (2022) Diagnostics for dermatologic diseases with autoantibodies. J Appl Lab Med 7(1):165\u2013196. https:\/\/doi.org\/10.1093\/jalm\/jfab147","journal-title":"J Appl Lab Med"},{"issue":"15","key":"4273_CR41","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.15.17","volume":"64","author":"A Di Zazzo","year":"2023","unstructured":"Di Zazzo A, Cutrupi F, De Antoniis MG, Ricci M, Esposito G, Antonini M et al (2023) Tissue remodeling in ocular mucous membrane pemphigoid. Invest Ophthalmol Vis Sci 64(15):17. https:\/\/doi.org\/10.1167\/iovs.64.15.17","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"4273_CR42","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.3892\/etm.2020.8972","volume":"20","author":"DC Branisteanu","year":"2020","unstructured":"Branisteanu DC, Stoleriu G, Branisteanu DE, Boda D, Branisteanu CL, Maranducav MA et al (2020) Ocular cicatricial pemphigoid (Review). Exp Ther Med 20(4):3379\u20133382. https:\/\/doi.org\/10.3892\/etm.2020.8972","journal-title":"Exp Ther Med"},{"issue":"4","key":"4273_CR43","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1046\/j.1365-2133.1998.02168.x","volume":"138","author":"J Setterfield","year":"1998","unstructured":"Setterfield J, Shirlaw PJ, Kerr-Muir M, Neill S, Bhogal BS, Morgan P et al (1998) Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br J Dermatol 138(4):602\u2013610. https:\/\/doi.org\/10.1046\/j.1365-2133.1998.02168.x","journal-title":"Br J Dermatol"},{"issue":"6","key":"4273_CR44","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1167\/iovs.07-0691","volume":"49","author":"E Knop","year":"2008","unstructured":"Knop E, Knop N, Claus P (2008) Local production of secretory IgA in the eye-associated lymphoid tissue (EALT) of the normal human ocular surface. Invest Ophthalmol Vis Sci 49(6):2322\u20132329. https:\/\/doi.org\/10.1167\/iovs.07-0691","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"4273_CR45","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/0192623320970448","volume":"49","author":"JACL Schuh","year":"2021","unstructured":"Schuh JACL (2021) Mucosa-associated lymphoid tissue and tertiary lymphoid structures of the eye and ear in laboratory animals. Toxicol Pathol 49(3):472\u2013482. https:\/\/doi.org\/10.1177\/0192623320970448","journal-title":"Toxicol Pathol"},{"issue":"2020","key":"4273_CR46","doi-asserted-by":"publisher","first-page":"2032057","DOI":"10.1155\/2020\/2032057","volume":"3","author":"Y Li","year":"2020","unstructured":"Li Y, Jin L, Chen T, Pirozzi CJ (2020) The effects of secretory IgA in the mucosal immune system. Biomed Res Int 3(2020):2032057. https:\/\/doi.org\/10.1155\/2020\/2032057","journal-title":"Biomed Res Int"},{"issue":"3","key":"4273_CR47","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/cei.13390","volume":"199","author":"K Kobayashi","year":"2020","unstructured":"Kobayashi K, Suzukawa M, Watanabe K, Arakawa S, Igarashi S, Asari I et al (2020) Secretory IgA accumulated in the airspaces of idiopathic pulmonary fibrosis and promoted VEGF, TGF-\u03b2 and IL-8 production by A549 cells. Clin Exp Immunol 199(3):326\u2013336. https:\/\/doi.org\/10.1111\/cei.13390","journal-title":"Clin Exp Immunol"},{"key":"4273_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtos.2023.09.005","volume":"30","author":"J Panthagani","year":"2023","unstructured":"Panthagani J, Suleiman K, Vincent RC, Ong HS, Wallace GR, Rauz S (2023) Conjunctival transcriptomics in ocular mucous membrane pemphigoid. Ocul Surf 30:142\u2013149. https:\/\/doi.org\/10.1016\/j.jtos.2023.09.005","journal-title":"Ocul Surf"},{"issue":"2","key":"4273_CR49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/cei.12636","volume":"181","author":"L Ten Klooster","year":"2015","unstructured":"Ten Klooster L, van Moorsel CHM, Kwakkel-van Erp JM, van Velzen-Blad H, Grutters JC (2015) Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis. Clin Exp Immunol 181(2):357\u2013361. https:\/\/doi.org\/10.1111\/cei.12636","journal-title":"Clin Exp Immunol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04273-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:55:43Z","timestamp":1789102543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04273-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4273"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04273-7","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Andrea Smichowski is employee of Janssen. All other authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"394"}}